Recursion Pharmaceuticals... (RXRX)
NASDAQ: RXRX
· Real-Time Price · USD
5.70
0.06 (1.06%)
At close: Aug 15, 2025, 10:57 AM
Recursion Pharmaceuticals Fail-to-Deliver
Total FTD Shares
374.16K
Above Average
FTD / Avg. Volume
1.34%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Recursion Pharmaceuticals Inc. has
374,160
shares failed to deliver, representing 1.34%
of the average daily volume of
27,996,864
shares. Over the past year, the monthly average FTD is
263,780
shares, with the current level 42% above
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 5.28 | 374.16K | -53.58% |
Jun 30, 2025 | 5.06 | 805.95K | +152.22% |
May 30, 2025 | 4.18 | 319.55K | +4789.06% |
Apr 30, 2025 | 5.59 | 6.54K | +771.47% |
Mar 28, 2025 | 5.81 | 750 | -98.37% |
Feb 28, 2025 | 7.51 | 46.03K | +98.89% |
Jan 31, 2025 | 7.24 | 23.14K | -62.74% |
Dec 31, 2024 | 6.76 | 62.12K | -98.51% |
Nov 29, 2024 | 7.07 | 4.18M | +4178302.00% |
Oct 30, 2024 | 6.68 | 100 | -99.53% |
Sep 30, 2024 | 6.59 | 21.12K | +35105.00% |
Aug 30, 2024 | 7.28 | 60 | -97.71% |
Jul 30, 2024 | 7.95 | 2.63K | -33.70% |
Jun 28, 2024 | 7.5 | 3.96K | -64.35% |
May 29, 2024 | 8.58 | 11.1K | -87.13% |
Apr 30, 2024 | 7.82 | 86.25K | +52172.73% |
Mar 27, 2024 | 10.17 | 165 | -99.56% |
Feb 29, 2024 | 13.46 | 37.53K | +17601.42% |
Jan 31, 2024 | 9.41 | 212 | -44.21% |
Dec 28, 2023 | 10.61 | 380 | -97.57% |
Nov 30, 2023 | 6.85 | 15.65K | -87.22% |
Oct 31, 2023 | 5.28 | 122.48K | +888.05% |
Sep 28, 2023 | 7.77 | 12.4K | +3250.27% |
Aug 14, 2023 | 9.32 | 370 | -87.00% |
Jul 31, 2023 | 14.12 | 2.85K | +421.43% |
Jun 30, 2023 | 7.47 | 546 | +12.81% |
May 31, 2023 | 8.77 | 484 | +93.60% |
Apr 27, 2023 | 4.89 | 250 | -62.18% |
Mar 30, 2023 | 6.45 | 661 | -82.10% |
Feb 28, 2023 | 8.15 | 3.69K | -4.05% |
Jan 31, 2023 | 8.33 | 3.85K | n/a |